Biolytical Laboratories Inc., founded in 2002 and based in Canada, is a leader in rapid in vitro diagnostic tests for infectious diseases. Their mission is to ensure global access to fast testing, starting with the development of the INSTI® HIV test, which provides results in just one minute from a drop of blood and is approved by the US FDA, Health Canada, and CE in Europe. The proprietary INSTI® platform, along with the iStatis lateral-flow system, reliably detects infectious diseases through antibodies and antigens.